CAR-T cell therapy for cancer: The patient's in the process
Around 1,000 people are diagnosed with cancer every day in the UK. Fortunately, outcomes continue to improve, with around half of those diagnosed...
PDF File: Cell and Gene Therapy: What are ATMPs and why do they matter?
Welcome to part 2 of our Cell and Gene blog series. Click the pdf link above to access the second blog.
This second blog provides a primer to 'ATMPs', looking at what they are why they matter. The reader will get an insight into some of the historical context and various technologies behind ATMPs.
Around 1,000 people are diagnosed with cancer every day in the UK. Fortunately, outcomes continue to improve, with around half of those diagnosed...
In this latest blog, James Lau, one of 3P’s Project Engineers, tells us all about barrier systems across a range of areas. Specifically taking a...
In early-stage pharmaceutical development, poor powder flow is rarely the root issue, it’s simply a symptom. The real challenge for formulation...